Annual Total Long Term Liabilities
$3.03 M
+$924.00 K+43.87%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual total long term liabilities is $3.03 million, with the most recent change of +$924.00 thousand (+43.87%) on December 31, 2023.
- During the last 3 years, VVOS annual total long term liabilities has risen by +$2.46 million (+432.51%).
- VVOS annual total long term liabilities is now at all-time high.
Performance
VVOS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$2.56 M
-$296.00 K-10.38%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly total long term liabilities is $2.56 million, with the most recent change of -$296.00 thousand (-10.38%) on September 30, 2024.
- Over the past year, VVOS quarterly long term liabilities has stayed the same.
- VVOS quarterly long term liabilities is now -25.14% below its all-time high of $3.41 million, reached on September 30, 2020.
Performance
VVOS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
VVOS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.9% | 0.0% |
| 3 y3 years | +432.5% | +610.0% |
| 5 y5 years | +148.4% | +703.8% |
VVOS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +372.7% | -20.2% | +298.8% |
| 5 y | 5-year | at high | +432.5% | -25.1% | +703.8% |
| alltime | all time | at high | +432.5% | -25.1% | +703.8% |
Vivos Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.56 M(-10.4%) |
| Jun 2024 | - | $2.85 M(-9.5%) |
| Mar 2024 | - | $3.15 M(+4.0%) |
| Dec 2023 | $3.03 M(+43.9%) | $3.03 M(-2.4%) |
| Sep 2023 | - | $3.10 M(-3.1%) |
| Jun 2023 | - | $3.20 M(+50.2%) |
| Mar 2023 | - | $2.13 M(+1.2%) |
| Dec 2022 | $2.11 M | $2.11 M(-18.4%) |
| Sep 2022 | - | $2.58 M(-9.2%) |
| Jun 2022 | - | $2.84 M(+53.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $1.85 M(+188.6%) |
| Dec 2021 | $641.00 K(+12.7%) | $641.00 K(+78.1%) |
| Sep 2021 | - | $360.00 K(+0.4%) |
| Jun 2021 | - | $358.40 K(+12.7%) |
| Mar 2021 | - | $318.00 K(-44.1%) |
| Dec 2020 | $569.00 K(-59.4%) | $569.00 K(-83.3%) |
| Sep 2020 | - | $3.41 M(+10.7%) |
| Jun 2020 | - | $3.08 M(+120.2%) |
| Dec 2019 | $1.40 M(+14.8%) | $1.40 M |
| Dec 2018 | $1.22 M | - |
FAQ
- What is Vivos Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Vivos Therapeutics?
- What is Vivos Therapeutics annual total long term liabilities year-on-year change?
- What is Vivos Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly long term liabilities year-on-year change?
What is Vivos Therapeutics annual total long term liabilities?
The current annual total long term liabilities of VVOS is $3.03 M
What is the all time high annual total long term liabilities for Vivos Therapeutics?
Vivos Therapeutics all-time high annual total long term liabilities is $3.03 M
What is Vivos Therapeutics annual total long term liabilities year-on-year change?
Over the past year, VVOS annual total long term liabilities has changed by +$924.00 K (+43.87%)
What is Vivos Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of VVOS is $2.56 M
What is the all time high quarterly long term liabilities for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly total long term liabilities is $3.41 M
What is Vivos Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, VVOS quarterly total long term liabilities has changed by $0.00 (0.00%)